Zealand Pharma Aktieselskabet

DK0060257814-DKK 
(SWI) 
 

Company Profile

Description
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates.
Key Stats
Website:
Headquarter country:
Employees: 0
Market Cap (at close ):
Fiscal Year Ends:

Stats



Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return of Assets
Return on Equity
Return on Invested Capital
20182017201620152014

Dividend


Dividend/Share
Ex. Dividend Date
Trailing Dividend Yield
Payout Ratio





Date Currency Amount

Income Statement DKK



Revenue
Total Revenue
Gross Profit
Gross Margin %
EBITDA
Net Income
Basic Earnings Per Share

Operating Expenses
Operating Income
Operation Margin %
20182017201620152014


Cash Flow DKK



Operating Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow
20182017201620152014


Balance Sheet DKK



Assets
Current Assets
Long Term Assets
Total Assets

Liabilities
Total Current Liabilities
Long Term Liabilities
Total Liabilities

Equity
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets
31-12-201831-12-201731-12-201631-12-201531-12-2014



Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. september 2019 16:59:21
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190829.2 - EUROWEB6 - 2019-09-20 16:59:21 - 2019-09-20 16:59:21 - 1 - Website: OKAY